Endologix Establishes a $20 Million Revolver With Bank of America

Endologix (NASDAQ: ELGX) established a $20 million bilateral revolving credit facility with Bank of America, which refinanced in full their prior Wells Fargo facility. Endologix, based in Irvine, develops and manufactures minimally invasive treatments for aortic disorders, and focuses on endovascular stent grafts for the treatment of abdominal aortic aneurysms.